Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126108022 | 12610802 | 2 | F | 201606 | 20160816 | 20160801 | 20160819 | PER | US-PFIZER INC-2016332491 | PFIZER | 93.00 | YR | F | Y | 65.77000 | KG | 20160819 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126108022 | 12610802 | 1 | PS | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, 2X/DAY | C110943 | 20998 | 200 | MG | CAPSULE, HARD | BID | |||||
| 126108022 | 12610802 | 2 | C | ACCUPRIL | QUINAPRIL HYDROCHLORIDE | 1 | ONE IN THE MORNING AND ONE AT NIGHT | 0 | 1 | DF | BID | ||||||||
| 126108022 | 12610802 | 3 | C | ACCUPRIL | QUINAPRIL HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126108022 | 12610802 | 1 | Arthritis |
| 126108022 | 12610802 | 2 | Blood disorder |
| 126108022 | 12610802 | 3 | Cardiac disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126108022 | 12610802 | Condition aggravated | |
| 126108022 | 12610802 | Drug dose omission | |
| 126108022 | 12610802 | Pain in extremity | |
| 126108022 | 12610802 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |